Tuberculosis Infections and Infestations Tuberculosis
Conditions
Interventions
Scheme one: experimental arm -
Each patient attending during this week will be requested to provide:
1. One on-the-spot sputum sample at the time of the patient's first visit
2. A second on-the-spot
Sponsors
Liverpool School of Tropical Medicine (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Symptoms suggesting pulmonary TB: persistent cough (generally greater than two weeks) 2. Provision of informed consent to participation 3. Age greater than 18 years old, either sex
Exclusion criteria
Exclusion criteria: 1. Inability to provide informed consent (e.g., unfamiliarity with language of patient information/consent forms, prisoners, mentally impaired) 2. Anti-tuberculous treatment in the last month
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. Sensitivity, specificity, positive and negative predictive value of: 1.1. A single positive smear 1.2. A single positive smear considering smears with scanty acid-fast bacilli (AFB) as positive 1.3. The smears collected as spot, extra-spot and morning or spot-morning-spot 2. Proportion of patients with positive culture identified by two smears prepared from a single specimens 3. The incremental yield of the second and third samples | — |
Primary
| Measure | Time frame |
|---|---|
| These outcomes will be established for each diagnostic strategy and will use culture as gold standard: 1. Sensitivity, specificity, positive and negative predictive value of smear microscopy when using: 1.1. The WHO case definitions for smear-positive tuberculosis 1.2. The first two specimens collected by each strategy (spot and extra-spot versus spot and morning) 2. The number of patients referred to a TB treatment centre 24, 48 and 72 hours after their initial consultation 3. The number of patients who drop out of the diagnostic process | — |
Countries
Brazil, Ethiopia, Nepal, Nigeria, Yemen
Outcome results
None listed